Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome

被引:50
|
作者
Park, Joongkyu
Yang, Eun Jin
Yoon, Joo Heon
Chung, Kwang Chul
机构
[1] Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea
[2] Yonsei Univ, Coll Med, Dept Med Sci, Seoul 120752, South Korea
[3] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul 120752, South Korea
基金
新加坡国家研究基金会;
关键词
Dyrk1A; Down syndrome; Alzheimer's disease; amyloid precursor protein; amyloid-beta; tau; apoptosis; neuronal differentiation;
D O I
10.1016/j.mcn.2007.07.007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Down syndrome (DS) is the most common genetic disorder, characterized by mental retardation, congenital heart abnormalities, and susceptibility to Alzheimer's disease (AD). Brain development of DS patients is associated with elevated apoptosis and abnormal neuronal differentiation. Those key features are closely associated with Man. genes mapped within Down syndrome critical region (DSCR) on human chromosome 21. Proline-directed serine/threonine kinase, Dyrk1A. is mapped within DSCR, and involved in the control of cell growth and postembryonic neurogenesis. Despite the potential involvement of Dyrk1A in neurodegeneration, its links to AD susceptibility and the neuropathology of DS patients are not yet clearly understood. Here, we report evidence supporting the correlation between Dyrk1A and neuropathology of DS. Our results show that Dyrk1A interacts with and directly phosphorylates tau and amyloid precursor protein in immortalized hippocampal progenitor H19-7 cells. In addition, the formation of tau inclusion and the enhanced generation of beta-amyloid fragment were detected in H19-7 cells that overexpressed Dyrk1A. Furthermore, these cells show a marked increase in apoptotic cell death under conditions of serum deprivation and also exhibit defects in neuronal differentiation. These results suggest that upregulation of Dyrk1A may cause AD-like pathogenesis and abnormal neurobiological features in DS patients. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:270 / 279
页数:10
相关论文
共 50 条
  • [21] Overexpression of Dyrk1A, a Down Syndrome Candidate, Decreases Excitability and Impairs Gamma Oscillations in the Prefrontal Cortex
    Ruiz-Mejias, Marcel
    Martinez de lagran, Maria
    Mattia, Maurizio
    Castano-Prat, Patricia
    Perez-Mendez, Lorena
    Ciria-Suarez, Laura
    Gener, Thomas
    Sancristobal, Belen
    Garcia-Ojalvo, Jordi
    Gruart, Agnes
    Delgado-Garcia, Jose M.
    Sanchez-Vives, Maria V.
    Dierssen, Mara
    JOURNAL OF NEUROSCIENCE, 2016, 36 (13): : 3648 - 3659
  • [22] DYRK1A gene linked to heart defects in Down syndrome
    Fernandez-Ruiz, Irene
    NATURE REVIEWS CARDIOLOGY, 2024, 21 (04) : 217 - 217
  • [23] Overexpression of DYRK1A Located in the Down Syndrome Critical Region, Leads to Primary Hypothyroidism in Down Syndrome through Interaction with FOXE1
    Kariyawasam, Dulanjalee
    Carre, Aurore
    Rachdi, Latif
    Polak, Michel
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 55 - 56
  • [24] A commentary on: Overexpression of Dyrk1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome
    Dierssen, Mara
    EXPERIMENTAL NEUROLOGY, 2013, 247 : 110 - 112
  • [25] Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome
    Garcia-Cerro, Susana
    Martinez, Paula
    Vidal, Veronica
    Corrales, Andrea
    Florez, Jesus
    Vidal, Rebeca
    Rueda, Noemi
    Arbones, Maria L.
    Martinez-Cue, Carmen
    PLOS ONE, 2014, 9 (09):
  • [26] DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies
    Becker, Walter
    Soppa, Ulf
    Tejedor, Francisco J.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (01) : 26 - 33
  • [27] Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome
    McElyea, Samantha D.
    Starbuck, John M.
    Tumbleson-Brink, Danika M.
    Harrington, Emily
    Blazek, Joshua D.
    Ghoneima, Ahmed
    Kula, Katherine
    Roper, Randall J.
    HUMAN MOLECULAR GENETICS, 2016, 25 (22) : 4856 - 4869
  • [28] Understanding the Multifaceted Role of Human Down Syndrome Kinase DYRK1A
    Kay, L. J.
    Smulders-Srinivasan, T. K.
    Soundararajan, M.
    INSIGHTS INTO ENZYME MECHANISMS AND FUNCTIONS FROM EXPERIMENTAL AND COMPUTATIONAL METHODS, 2016, 105 : 127 - 171
  • [29] Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene
    Garcia-Cerro, Susana
    Vidal, Veronica
    Lantigua, Sara
    Teresa Berciano, Maria
    Lafarga, Miguel
    Ramos-Cabrer, Pedro
    Padro, Daniel
    Rueda, Noemi
    Martinez-Cue, Carmen
    NEUROBIOLOGY OF DISEASE, 2018, 110 : 206 - 217
  • [30] Involvement of Dyrk1A, a down syndrome candidate gene, in the thalamocortical connectivity
    Martinez De Lagran, M.
    Ruiz-Mejias, M.
    Sanchez-Vives, M.
    Dierssen, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S444 - S445